Brief: U.S. FDA Approves Removal Of "Not For Home Use" Label Restriction For Pliaglis
Dec 17 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* U.S. FDA APPROVES REMOVAL OF "NOT FOR HOME USE" LABEL
RESTRICTION FOR PLIAGLIS®
* CRESCITA THERAPEUTICS - FDA APPROVED PRIOR APPROVAL
SUPPLEMENT
FOR PLIAGLIS FOLLOWING MANDATED 6-MONTH REVIEW PROCESS, IN LINE
WITH PDUFA DATE
Source text for Eikon: ID:nCNWc1F4za
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium